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A Novel Bcl-x Isoform Connected
to the T Cell Receptor
Regulates Apoptosis in T Cells
An important advance in our understanding of genetic
regulation of T cell apoptosis has come from the descrip-
tion of the Bcl gene family (reviewed by Akbar et al.,
1993; Nunez et al., 1994; Reed, 1994; Cory, 1995; Hock-
enberry, 1995). Within this group, the Bcl-x gene en-
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codes several alternatively spliced protein isoforms thatHarvard Medical School
can enhance or diminish T cell apoptosis after transfec-Boston, Massachusetts 02115
tion (Boise et al., 1993; Hockenberry et al., 1993; Nunez
et al., 1994; Ma et al., 1995), and studies of mice deficient
in Bcl-x have suggested that at least some members ofSummary
this family can prolong the lifespan of double-positive
(DP) thymocytes by inhibition of apoptosis, although theWe define a novel Bcl-x isoform, Bcl-xg, that is gener-
precise contribution of these isoforms to this processated by alternative splicing and characterized by a
has not been established (Ma et al., 1995; Motoyama etunique 47 amino acid C-terminus. Bcl-xg is expressed
al., 1995).primarily in thymocytes, where it may depend on an
The Bcl-xL isoform can inhibit cell death upon growthinteraction between the TCR and host MHC products,
factor withdrawal (Boise et al., 1993), and overexpres-and in mature T cells, where its expression is associ-
sion leads to increased numbers of mature thymocytesated with ligation of the T cell receptor. Overexpres-
(Chao et al., 1995; Grillot et al., 1995), although appar-sion of Bcl-xg in T cells inhibits activation-induced
ently it does not affect negative selection (Grillot et al.,apoptosis; inhibition of Bcl-xg, after stable expres-
1995; Takahashi et al., 1997). A second Bcl-x isoform,sion of Bcl-xg antisense cDNA, enhances activation-
Bcl-xS, encodes a smaller protein of 170 amino acidsinduced apoptosis. In contrast to other Bcl-x isoforms,
(aa) that may enhance apoptosis in non-T cells undercells that fail to express Bcl-xg after CD3 ligation un-
certain conditions (Clarke et al., 1995; Minn et al., 1996).dergo programmed cell death, while activated T cells
Recently, the murine Bcl-x gene family has been ex-that express Bcl-xg are spared. Identification of Bcl-
panded to include two additional isoforms, Bcl-xDTMxg helps provide a molecular explanation of T cell acti-
and Bcl-xb, which may inhibit apoptosis in B cells (Fangvation and death after antigen engagement.
et al., 1994) and neurons (Gonzalez-Garcia et al., 1995),
respectively. Although these and other isoforms of Bcl-xIntroduction
may also regulate T cell growth and development, the
full complement of Bcl-x isoforms that participate in thisLigation of the T cell receptor (TCR) on thymocytes and
process is not yet clear.mature T cells leads to either successful cellular activa-
All of the murine Bcl-x isoforms described so far aretion and proliferation or to apoptosis. Until recently,
expressed in virtually all tissues, and there has been no
apoptosis following cellular activation was thought to
evidence for a T cell±specific isoform whose expression
be limited to thymocytes, where it represents the major
is tightly connected to TCR ligation. Here we show that
mechanism of negative selection in developing T cell
alternative splicing of Bcl-x generates a novel Bcl-x iso-
clones. More recently, it became clear that the response
form, termed Bcl-xg, which carries a unique C-terminus
of peripheral T cells is also regulated by activation-
and is expressed primarily in T cells. Unlike previously
induced cell death (Weber et al., 1995).
described isoforms, Bcl-xg is specifically connected to
Immunization with high doses of peptide (Pircher et TCR ligation and is essential for resistance to TCR-
al., 1989; Rocha et al., 1991; Zhang et al.,1994) or retrovi-
dependent apoptosis.
ral superantigens (Webb et al., 1990; Ignatowicz et al.,
1992) leads to transient clonal activation followed by Results
widespread T cell elimination. Infection with high doses
of lymphocytic choriomeningitis virus also results in Structural Characteristics of Bcl-xg
rapid T cell activation followed by massive clonal dele- Since previously isolated Bcl-x isoforms that display
tion within 1±2 weeks (Zinkernagel et al., 1993). These ubiquitous expression were derived from non-T cell
observations led to deliberate induction of apoptosis of cDNA libraries, we screened a mouse thymus l Zap II
autoreactive T cells by in vivo administration of high cDNA library using a 60-mer synthetic oligonucleotide
doses of autoantigen (Critchfield et al., 1994). The impli- probe specific for a conservedsequence of human Bcl-x
cation of these and other studies is that T cell activation (423±483 base pairs [bp]) (Boise et al., 1993). We isolated
followed by apoptosis isa common response phenotype and purified six clones (Bcl-x5, Bcl-x6, Bcl-x7, Bcl-x8,
that can regulate both primary T cell responses and the Bcl-x10, and Bcl-x11); four contained inserts of the same
development of immunological memory. However, we length and sequence and corresponded to Bcl-xL cDNA
do not understand the TCR-linked signaling events re- and a fifth to Bcl-xb (GenBank accession numbers
sponsible for T cell activation on the one hand, and for U51279 and U51278) (Fang et al., 1994; Gonzalez-Garcia
apoptosis on the other. et al., 1994). One clone, termed Bcl-x7 (GenBank acces-
sion number U51277), contained a 1384 bp insert com-
posed of a 59 noncoding region of 377 nucleotides, an*To whom correspondence should be addressed.
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open reading frame (ORF) of 708 nucleotides, and a 39
noncoding region of 299 nucleotides (Figure 1A). This
represented a novel isoform of the Bcl-x gene in which
the 39 coding region of Bcl-xL was replaced by a 144
bp sequence that predicts a unique C-terminus of 47
aa (Figure 1A). This insert did not represent a cloning
artifact because the novel 144 bp subsequence begins
precisely at a conserveddonor/acceptor splice siteused Figure 2. Analysis of Protein Products of Bcl-xL, Bcl-xS, Bcl-xb,
and Bcl-xg on 12% SDS-PAGE after In Vitro Transcription and Trans-by murine and human Bcl-x isoforms (Boise et al., 1993;
lationFang et al., 1994; Gonzalez-Garcia et al., 1994) (Figure
The apparent size of Bcl-xg protein after in vitro transcription/trans-1B), and the sequence was independently cloned from
lation is consistent with the size predicted from its ORF, since thethymocyte RNA (using a primer specific for a conserved
Bcl-xg protein product migrates at a position similar to Bcl-xL (233
region of murine Bcl-x and a Bcl-x7±specific primer). aa residues) (see Figure 1B) and more slowly than the Bcl-xb protein
The recovered thymic sequence was identical to the (209 aa) and Bcl-xS (170 aa). Molecular weight standards (kilodal-
cDNA insert isolated from the l Zap II cDNA library, and tons) are indicated at the left margin.
the new isoform was designated Bcl-xg.
In vitro transcription and translation assays using lin-
earized recombinant Bcl-x plasmids were performed to insertion of an ankyrin-like domain affects dimerization
and DNA binding (Klein et al., 1993). In the first twoconfirm the length of the ORF deduced from the cDNA
sequence of Bcl-xg (Figure 2). As expected from the cases, four to seven ankyrin repeats are present and
may be required for physiological function, while in thepredicted Bcl-xg ORF of 708 nucleotides/235 aa, the
apparent size of the translated Bcl-xg protein was latter case, tissue-specific RNA splicing of a single an-
kyrin-like domain regulates basic±helix-loop-helix di-slightly larger than the (233 aa) Bcl-xL protein product
and considerably larger than both the (170 aa) Bcl-xS merization and DNA binding (Klein et al., 1993).
(Fang et al., 1994) and the (209 aa) Bcl-xb proteins (Gon-
zalez-Garcia et al., 1994). Analysis of the hydrophobicity Expression of Bcl-xg
To ensure accurate and semiquantitative measurement,of the unique C-terminus of the Bcl-xg protein indicated
that Bcl-xg lacks an obvious hydrophobic domain by reverse transcriptase polymerase chain reaction (RT-
PCR), expression of Bcl-xg and other Bcl-x isoforms,flanked by charged residues (Figure 1C), which are pres-
ent in human and murine Bcl-xL and Bcl-xS (Hocken- equal amounts of total RNA from each cellular sample
was reverse transcribed, and amplification curves forberry et al., 1990; Boise et al., 1993; Nguyen et al., 1993).
Differential centrifugation of Bcl-xg±transfected cellular each primer pair (for each Bcl-x isoform, interferon-g
[IFNg], interleukin-2 [IL-2], and b-actin) were plottedextracts (Yang et al., 1995) has indicated that Bcl-xg
protein is present mainly in the cytosol rather than mem- against increasing cycles of PCR. This analysis showed
that the slopes of these curves were similar (data notbrane subcellular fraction (manuscript in preparation),
similar to Bcl-xDTM (Fang et al., 1994). A 33 aa region shown), suggesting that a potential bias reflecting dif-
fering amplification efficiencies of different primer pairswithin the C-terminal domain of Bcl-xg shows strong
homology with the consensus sequence of the ankyrin- was minimal.
Samples of the reaction mix were taken from cycleslike domains (Figure 1D) that are embedded in a number
of intracellular proteins, including Bcl-3, which uses this in the exponential portion of the PCR reaction for mea-
surement and comparison of gene expression, as pre-subsequence to bind to NF-kB p50 (Hatada et al., 1992);
the p53 binding protein 53BP2, which uses the ankyrin- viously described (Moore et al, 1994; Zheng and Flavell,
1997). According to RT-PCR, Bcl-xL (as well as Bcl-xblike domains to bind toL2 loop of p53 (Gorinaand Pavlet-
ich, 1996); and bHLH (basic±helix-loop-helix), in which and Bcl-xDTM [data not shown]) was expressed in all
Figure 1. Molecular Features of Bcl-xg
(A) cDNA sequence and predicted protein sequence of Bcl-xg (GenBank accession number U51277). The position of the ORF encoding Bcl-
xg protein is indicated, and the predicted amino acid sequence (numbered to the right of each sequence) is given below the nucleotide
sequence. Arrow, the splice site at which the unique Bcl-xg C-terminus (continuously underlined) begins; long-dashed underline and a short-
dashed underline, the conserved BH1 and BH2 domains, respectively.
(B) Schematic comparison of murine Bcl-x isoforms: Bcl-xL, Bcl-xS, Bcl-xb, Bcl-xDTM, and Bcl-xg. Murine Bcl-x isoforms share a long
N-terminal region (hatched). The BH1/BH2 region between splice sites 1 and 2 of Bcl-xS is shown. Splice site 2, used to generate Bcl-xb and
Bcl-xg, is compared to the noncanonical splice site used to generate Bcl-xDTM (located five residues downstream from splice site 2). The
distinct C-termini of Bcl-xb, Bcl-xDTM, and Bcl-xg, which show no homology with Bcl-xL and Bcl-xS C-terminal regions, also are shown,
along with the positions of conserved BH1/BH2 domains. The position of the oligonucleotide probe used here to screen a mouse thymus
cDNA library is indicated.
(C) Hydrophobicity plot of Bcl-xL and Bcl-xg. The hydrophobicity of Bcl-xL and Bcl-xg was calculated using the GCG program based on
Goldman's (solid line) or Kyte-Doolittle's (dashed line) algorithm. The amino acid sequence of Bcl-xL and Bcl-xg is numbered above and
below the hydrophobicity plots. Vertical line, the beginning of the isoform-specific C-terminal sequences of Bcl-xg and Bcl-xL; vertical arrow,
the hydrophobic segment representing a putative membrane anchoring domain of Bcl-xL.
(D) Alignment of the specific region of mouse Bcl-xg with the consensus sequence of the ankyrin-like domain sequence. The consensus
sequence of ankyrin-like domain is shown. Amino acid symbols: bold and underlined, the six residues in Bcl-xg that are identical to ankyrin
consensus residues; bold, the two highly conserved residues in Bcl-xg; underlined, three residues in Bcl-xg with homology to the ankyrin
consensus residues. Dashed lines, the correct spacing of the ankyrin-like motif.
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Figure 3. Tissue Expression of Bcl-xg
(A) Expression of Bcl-xg in different murine tissues. RT-PCR products were analyzed on 1% agarose gels stained with ethidium bromide.
Molecular weight markers are indicated at the right margin of the gels. The amount of amplified Bcl-xg fragment and amplified b-actin fragment
both increased in proportion to the number of thermal cycles, and the PCR amplification efficiency of Bcl-xg primer pair was similar to that
of the b-actin primer pair used as an internal control for RT-PCR for each tissue cDNA. Levels of b-actin from these tissues in the linear phase
of PCR before saturation of amplification indicated that the actual amount of cDNA from each tissue used in this analysis was similar. A Bcl-
xL fragment was also amplified to determine potential differences in tissue expression of Bcl-x isoforms. As reported previously, Bcl-xL was
detected in every tissue examined. In contrast, the Bcl-xg fragment was detected in thymus (T) and eye (E) but not in brain (B), heart (H),
intestine (I), kidney (K), or liver (L). The specificity of the Bcl-xg fragments from the tissues scoring as positive was confirmed by a Southern
blot hybridization using a [32P]dCTP-labeled Bcl-xg±specific probe that did not overlap with either primer of Bcl-xg used in the RT-PCR.
(B) Expression of Bcl-xg in lymph nodes of normal, nu/nu, and Rag22/2 mice. Analysis of cDNA indicated that Bcl-xg is amplified in lymph
nodes of normal but not nu/nu donors (PCR amplification of b-actin fragment served as control). To measure the linear phase of PCR
amplification, aliquots of reaction mix were tested at 27, 31, and 35 cycles for b-actin and at 37, 41, and 45 cycles for Bcl-xg and were
visualized by agarose gel electrophoresis and ethidium bromide staining. The specificity of Bcl-xg fragments amplified was confirmed by a
Southern blot hybridization as described in (A); the blot was overexposed to detect any weak hybridization.
(C) Expression of Bcl-xg in thymocyte subpopulations. Expression of Bcl-xg was not detected in DN (CD42CD82) thymocytes (either CD441
or CD442) from normal, Rag22/2, or TCRb2/2 donors. Bcl-xg was detected in normal thymocytes, and DP (90%) and single-positive thymocytes
(after depletion of DN cells) according to RT-PCR. PCR analysis of thymocytes from MHC2/2 mice also showed that expression of MHC
products are required for expression of Bcl-xg but not Bcl-xL and Bcl-xS. The specificity of Bcl-xg fragments amplified was confirmed by
Southern blot hybridization, as described (A); the blot was overexposed to detect weak hybridization in PCR lanes that did not show apparent
hybridization (negative groups).
tissues tested, including brain, eyes, heart, intestine, not result from degradation of preparations of RNA from
these tissues, since the ratio of ethidium bromide±kidney, liver, and thymus (Figure 3A), consistent with
previous reports (Boise et al., 1993; Gonzalez-Garcia et stained 28S to 18S rRNA bands in agarose gels was the
same for all tissues (data not shown), and since Bcl-xL,al., 1994). In contrast, Bcl-xg expression was detected
in thymus, lymph node, and eye, but not brain, heart, the b-actin gene, and other genes were successfully
amplified by RT-PCR from the same RNA samples thatintestine, kidney, or liver (Figure 3A). The specificity of
the amplified Bcl-xg fragments in these tissues was con- were negative for Bcl-xg. These results indicate that
expression of the Bcl-xg isoform in murine tissues isfirmed by Southern blotting with a Bcl-xg±specific probe
that did not overlap with the sequences of the primers more restricted than is expression of other members of
the Bcl-x family (Fang et al., 1994; Gonzalez-Garcia et(Figure 3A). Failure to detect Bcl-xg in tissues such as
brain, heart, intestine, kidney, and liver by RT-PCR did al., 1994).
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We asked whether expression of Bcl-xg in lymphoid T cells using antibodies to the common region of Bcl-x.
We therefore used a glutathione S-transferase (GST)tissues was restricted to T cells, B cells, or monocytes.
Bcl-xg was not expressed in peripheral lymphoid tissues fusion protein containing the Bcl-xg±specificC-terminus
to immunizerabbits. The resulting antisera, afterabsorp-of mice deficient in recombinase-activating gene-2
(Rag2), consistent with its selective expression in lym- tion on GST columns, specifically reacted with Bcl-xg
and not with Bcl-xL or GST by Western blot analysisphocytes. Furthermore, Bcl-xg was expressed in lymph
nodes of BALB/c but not BALB/c nu/nu mice, sug- (Figure 4C). This antibody detected Bcl-xg as a single
species that comigrated with in vitro±translated Bcl-xggesting that its expression is confined to T lymphocytes
(Figure 3B). (34 kDa) within 12 hr after anti-CD3 stimulation of a T cell
hybridoma and within 24 hr after stimulation of purifiedAdditional analysis of Bcl-xg expression in the thymus
indicated that it is not detectable in double-negative splenic T cells (Figure 4D).
cells from normal or Rag22/2 donors, nor in thymocytes
from mice that are deficient in the TCR b chain and fail
Effect on T Cell Apoptosisto undergo TCR-dependent maturation into DP thymo-
Since studies of previously described Bcl-x isoformscytes. Bcl-xg is expressed by DP thymocytes, since
have indicated that they either enhance (Boise et al.,preparations that contained approximately 90% DP
1993; Clarke et al., 1995; Minn et al., 1996) or inhibitcells expressed Bcl-xg (Figure 3C), while purified single-
(Boise et al., 1993; Fang et al., 1994; Gonzalez-Garciapositive thymocytes did not express detectable Bcl-
et al., 1994, 1995) apoptosis, we asked whether stablexg (data not shown). These results suggest that Bcl-xg
Bcl-xg expression after transfection into a T cell lineexpression in thymocytes is similar to that of Bcl-xL, as
might regulate programmed cell death following TCRreported by others using different approaches (Boise et
ligation. CTLL-2 transfectants that stably overexpressedal., 1993; Ma et al., 1995; data not shown).
Bcl-xg (pRC/gC4) expressed increased constitutive lev-Bcl-xg expression in DP thymocytes may depend on
els of Bcl-xg protein (Figure 5A) and, after CD3 ligation,engagement of the TCR by major histocompatibility
displayed almost complete inhibition of apoptosis com-complex (MHC)/peptide ligands in the thymus, since
pared to vector control transfectants (pRC/RSV). ForBcl-xg was not detectable in thymocytes from mutant
example, CD3 ligation leading to approximately 70%mice deficient in MHC class I/II (MHC double-deficient
apoptosis of pRC/RSV transfectants led to about 10%mice), which we have shown consist of approximately
apoptosis of pRC/gC4 transfectants (Figure 5B).90% DP cells (Crump et al., 1993) (Figure 3C). By con-
We examined the effects of deliberate inhibition oftrast, expression of Bcl-xL and Bcl-xS (and Bcl-xb and
Bcl-xg on activated-induced apoptosis. CTLL-2 cellsBcl-DTM; data not shown) was unchanged in thymo-
were stably transfected with a Bcl-xg antisense vectorcytes from MHC double-deficient mice, indicating that,
pRC/gAS.A3 containing a 0.4 kb Bcl-xg fragment in re-unlike Bcl-xg, expression of Bcl-xL and Bcl-S isoforms
verse orientation, so that the complementary (antisense)in the thymus is not obviously dependent on MHC
strand of Bcl-xg would be expressed. Overexpressionproducts.
of Bcl-xg±specific antisense transcripts in pRCgAS.A3
transfectants had no detectable nonspecific toxic ef-
fects, as judged by 3H-labeled thymidine incorporationAssociation with the TCR
Bcl-xg expression was not detectable in the resting mu- or thesurvival rate of nonactivated cells according to pro-
pidium iodide (PI) staining (data not shown). However,rine T helper 1 (Th1) clone O3 but increased substantially
by 4 hr after CD3 ligation. In contrast, Bcl-xg was not expression of pRCgAS.A3 markedly enhanced receptor-
induced apoptosis (Figure 5C), presumably reflectingexpressed after IL-2 activation of these cells and re-
mained undetectable even after the number of PCR cy- specific inhibition of efficient translation of Bcl-xg mRNA
transcripts in activated T cells (Robinson-Benion andcles was increased to the maximal number (50 cycles)
before polymerase activity becomes limiting (Coen, Holt, 1995; Fakhrai et al., 1996).
These experiments indicate that T cells that do not1994), although [3H] TdR incorporation (data not shown)
was similar in both stimulation protocols (Figures 4A express Bcl-xg after activation might undergo apoptosis.
To address this question using nontransformed T cells,and 4B). By comparison, all other murine Bcl-x isoforms
(Bcl-xL, Bcl-xb, Bcl-xDTM, and Bcl-xS) were expressed we exploited the finding that activated T cells (including
Th1 clone O3) undergoing apoptosis after CD3 ligationin resting O3 cells and displayed similar increments 8
hr after either IL-2R or CD3 ligation (Figures 4A and 4B), stain intensely with Hoechst 33342 dye within 4±8 hr
after activation, while the Hoechst-negative subpopula-similar to the reported increases in these isoforms using
different techniques (Fang et al., 1994). TCR-dependent tion of activated T cells goes on to divide and produce
cytokines (Weber et al., 1995). Activated O3 cells wereexpression of Bcl-xg was not limited to nontransformed
primary T cell clones: neither of the T cell hybridomas analyzed for Bcl-x isoform expression after Hoechst-
based sorting of blast cells 5 hr after CD3 ligation. Bcl-AF3.G7 or RF33.70, nor the lymphoma cell line EL4,
expressed detectable Bcl-xg mRNA unless CD3 was xg was strongly expressed in the successfully activated
fraction but was not detectable in the Hoechst-positiveligated (data not shown).
We also documented that up-regulation of Bcl-xg at fraction destined to undergo apoptosis (Figure 4C), even
after maximum runs of 50 PCR cycles. In contrast, thethe RNA level after T cell activation was accompanied
by enhanced expression at the protein level. Since Bcl- Bcl-xL, Bcl-xb and Bcl-DTM isoforms were equally ex-
pressed in both the viable and apoptotic fractions ofxg is similar in size to the more abundantly expressed
Bcl-xL, it is difficult to detect Bcl-xg in unmanipulated activated T cells (Figure 6).
Immunity
634
Figure 4. Expression of Bcl-x Isoforms in Activated T Cells
(A) Expression of Bcl-x isoforms in activated T cells after CD3 liga-
tion. (Left) After exposure of O3 T cells to plate-bound anti-CD3
antibody for the indicated intervals, total RNA was extracted, and
RT-PCR amplification by an IL-2 and IFNg fragment indicated activa-
tion as early as 4 hr. Expression of all of Bcl-x isoforms was up-
regulated between 4 and 8 hr after stimulation, but the increase in
Bcl-xg expression was the most dramatic and returned to normal-
ized levels more quickly. Because of variations in the levels of ex-
pression among the different Bcl-x isoforms, the number of PCR
cycles used to measure the linear phase of PCR amplification varied
among the isoforms but was constant at all time points for each
given isoform. The specificity of Bcl-xg fragments amplified was
confirmed by a Southern blot hybridization as described in Figure
3A; the blot was overexposed to detect weak hybridization in nega-
tive PCRlanes (negative groups). (Right) Agarose gels were scanned
and quantitated using an IS-1000 digital imaging system, adjusting
for exposure times so that the intensity of DNA fragment signals
corresponded to the linear range of densitometric detection. To
ensure that comparisons of cDNA levels in different samples were
based upon the same amount of cDNA in each sample, the area
under the densitometric peak of each sample was divided by the
area under the b-actin densitometric peak for the corresponding
sample. The ratios of Bcl-x isoform and control (IL-2, IFNg) cDNA
to b-actin cDNA for each sample are shown as relative densitometric
units.
(B) Expression of Bcl-x isoforms in activated T cells after IL-2 stimu-
lation. (Left) After incubation of O3 T cells with 25 U/ml IL-2 resulting
in levels of [3H]TdR incorporation that were similar to that obtained after CD3 ligation, total RNA was extracted. Bcl-xL, Bcl-xb, and Bcl-xDTM
were up-regulated 4±24 hr after IL-2 treatment, but Bcl-xg expression was not detectable. (Right) The PCR-amplified fragments on agarose
gels were scanned, quantitated using the IS-1000 digital imaging system, and normalized as described above. The results indicate that
signaling through IL-2 receptor does not up-regulate the expression of Bcl-xg.
(C) Specificity of a rabbit anti-Bcl-xg antisera. (Top) Western blot analysis was performed to define the specificity of an antiserum raised in
rabbits immunized with a GST-fusion protein containing the Bcl-xg±specific C-terminus (outlined in bottom panel) (GST-Bcl-xg-C). After
absorption of antisera with a GST column, the IgG fraction reacts with GST-Bcl-xg-C but not GST (left) and with GST-Bcl-xg but not GST-
Bcl-xL (right) at a 1:2500 final dilution. (Bottom) Schematic representation of three GST fusion proteins used in these studies (see Experimental
Procedures and [B] for details).
(D) Expression of Bcl-xg protein in activated T cells after CD3 ligation detected by Western blotting
Western blots were performed using the anti-Bcl-xg IgG characterized in (C) at a final dilution of 1:2500 after 12% SDS-PAGE analysis of 10
mg/each of cell lysates prepared at the indicated times after exposure of RF33.70 cells (left) or splenic T cells (right). A protein that migrated
at approximately 34 kDa (consistent with the apparent size of Bcl-xg in Figure 5A) was detected within 12 hr of activation of a T cell hybridoma
RF33.70 and within 24 hr of activation of purified splenic T cells.
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Figure 5. The Effect of Overexpression of Bcl-xg Sense or Antisense
cDNA on T Cell Apoptosis
(A) Overexpression of Bcl-xg protein in stable Bcl-xg transfectants.
Western blot analysis (right) using a rabbit anti-Bcl-x common region
(1:1000 dilution) on blots of cell lysate (10 mg) from pRC/RSV (vector
control) or pRC/Bcl-xg CTLL-2 transfectants after 12% SDS-PAGE.
Autoradiographed (left) in vitro±translated Bcl-xL and Bcl-xg alone
or together on the same 12% SDS-PAGE were used as migration
markers for cellular Bcl-xL and Bcl-xg. pRC/Bcl-xg transfectants
but not vector control transfectants display a band that reacts with
anti-Bcl-x and comigrates with translated Bcl-xg at approximately
34 kDa. Figure 6. Expression of Bcl-x Isoforms in O3 T Cell Clone Stimulated
(B) Influence of Bcl-xg overexpression on T cell apoptosis. The by Plate-Bound Anti-CD3 Antibody for 5 hr and Sorted by Flow
cell cycle profile represents CTLL-2 cells that stably express the Cytometry
indicated constructs pRC/RSV (vector control), pRC/Bcl-xL, and (Left) After stimulation of the O3 T cell clone by plate-bound anti-
pRC/gC4 (Bcl-xg) after activation by plate-bound anti-CD3. The dis- CD3 antibody for 5 hr, cells were subjected to staining with Hoechst
tribution of cells between the G1, S, and G2/M phases of the cell 33342 dye and PI. After dead cells were gated out, activated cells
cycle are shown; the abscissa indicates the relative cell number were sorted into two subpopulations by flow cytometry, Hoechst-
and the ordinate indicates DNA content based on PI staining. The high (apoptotic) and Hoechst-low. Total RNA from both Hoechst-
numbers at top left represent the percentage of cells that display positive and Hoechst-negative subpopulations was extracted as
apparent DNA contents of less than diploid (subdiploid), corre- described in Experimental Procedures. RT-PCR amplification of
sponding to the subpopulation of apoptotic cells. These stable IFNg fragment and IL-2 fragment after stimulation by anti-CD3 in
transfectants expressed similar levels of CD3 according to immu- both Hoechst-high and Hoechst-low cells confirmed activation of
nofluoresence, and all had similar baseline levels of apoptosis (4%± O3. Bcl-xg was selectively expressed in Hoechst-low cells but not
10%; data not shown). Each panel represents one of triplicate wells; in Hoechst-high (apoptotic) cells, while all other Bcl-x isoforms are
results are representative of three experiments. expressed in both forms. Failure to detect Bcl-xg in Hoechst-high
(C) Comparison of apoptosis of Bcl-xg antisense (pRC/gAS.A3) cells did not result from degraded preparations of total RNA or
transfectants with vector control (pRC/RSV) transfectants. In experi- cDNA, since b-actin and other Bcl-x isoforms were detected in these
ments in which relatively low levels of apoptosis were obtained after samples.
incubation of transfectants on anti-CD3 coated plates, the degree (Right) The PCR-amplified fragments analyzed on agarose gel were
of apoptosis was substantially elevated in activated pRCgAS.A3 scanned and quantitated using an IS-1000 digital imaging system,
antisense transfectants, compared to vector-transfected controls followed by normalization, as described above.
(pRC/RSV). Each panel represents one of triplicate wells; results are
representative of three experiments.
thymocyte development, none of the isoforms discov-
ered to date is selectively expressed in thymocytes and
T cells. Instead, the knownBcl-x products areexpressedDiscussion
in virtually all tissues, can be induced by a variety of
stimuli (Fang et al., 1994; Gonzalez-Garcia et al., 1994),Differential splicing of individual genes can be an impor-
tant mechanism for generating lineage-specific proteins and may not regulate TCR-dependent selection in the
thymus (Grillot et al., 1995). Here we show that murinethat carry out distinct but related biological functions,
as exemplified by the expression of CD44 and CD45 Bcl-x generates a 235 aa protein isoform, marked by a
unique C-terminus, that is expressed primarily in acti-isoforms by different cell types (Kincade et al., 1993;
Novak et al., 1994). However, despite the potential im- vated T cells.
Bcl-xg, cloned and sequenced independently fromportance of differentially spliced Bcl-x gene products to
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Experimental Procedurestwo different cDNA libraries, contains a functional ORF
as judged by sequence analysis, in vitro transcription
Miceand translation, and overexpression as a GST fusion C57BL/6J, BALB/c, TCRb knockout, and BALB/c nu/nu mice were
protein in Escherichia coli. Transcription of Bcl-xg is purchased from the Jackson Laboratory (Bar Harbor, ME). MHC
detected by RT-PCR followed by Southern blotting in class I/II±deficient mice were kindly provided by L. H. Glimcher
(Harvard School of Public Health, Boston, MA). Rag2-deficient miceimmature DP thymocytes and may require MHC prod-
were kindly provided by F. W. Alt (Children's Hospital, Harvard Medi-ucts for its intrathymic expression. It is expressed at
cal School, Boston, MA).both the mRNA and the protein levels shortly after CD3-
mediated activation of T cells, and, unlike other Bcl-x
T Cellsisoforms, expression of Bcl-xg in peripheral T cells de-
Splenic T cells were isolated from BALB/c mice using rat anti-mouse
pends on signaling initiated by the TCR but not the IL-2 B220, Ly-6G, CD11b (Pharmingen, San Diego, CA), along with Dyna-
cytokine receptor. Overexpression of this Bcl-x isoform beads M450 sheep anti-rat IgG (Dynal), according to a modification
in a T cell line inhibits anti-CD3±induced apoptosis, while of the manufacturer's protocol. In brief, T cells were negatively iso-
lated from spleens of several mice and suspended in DMEM-2 (Dul-overexpression of a specific antisense transcript of Bcl-
becco's modified Eagle's medium supplemented with 2% fetal calfxg enhances apoptosis after TCR ligation. These results
serum) at 1 3 107 cells/ml. The lymphocytes were mixed with a poolstrongly argue that expression of Bcl-xg plays a critical
of specific antibodies including anti-mouse B220, anti-mouse Ly-
role in T cell survival after TCR ligation. 6G, and anti-mouse CD11b at 48C for 40 min. Lymphocytes were
Although other Bcl-x isoforms can be up-regulated in rinsed twice with DMEM-2 followed by incubation with Dynabeads
M450 sheep anti-rat IgG at 48C for 30 min. After magnetic separationT cells after TCR and IL-2R ligation, and overexpression
for 2 min, splenic T cells remaining in the supernatants were nega-of the Bcl-xL isoform can enhance T cell survival (Fang
tively selected.et al., 1994; Boise et al., 1995; Mueller et al., 1996),
CTLL-2 is a mouse T cell line derived from C57BL/6 (Broome etphysiologic expression of these Bcl-x isoforms is not
al, 1995). O3 is a murine CD41 Th1 clone derived from BALB/c mice
sufficient to confer resistance to apoptosis following after in vitro selection for proliferation to OVA in association with
TCR ligation, since they are expressed equally well in antigen-presenting cells of BALB/c (Friedman et al., 1987). The
AF3.G7 hybridoma, generated by fusing cow insulin±immuneapoptotic and nonapoptotic T cell blasts. In contrast,
C57BL/6 lymph node cells with the BW5147 thymoma line, ex-failure of Bcl-xg expression after CD3 ligation represents
presses a Vb61/Va3.21 TCR and responds to both cow insulin pep-a genetic marker of programmed cell death, while acti-
tide and to MTV-7, according to IL-2 production (Spinella et al.,
vated T cells that express Bcl-xg are spared. The tight 1987). EL4 is a mouse lymphoma cell line established in C57BL/6N
coupling of Bcl-xg expression to the TCR may ensure mice that produces high titers of murine IL-2 (Wein and Roberts,
that survival of activated T cells is governed by the 1965). The RF33.70 CD8 T cell hybridoma was kindly provided by K.
Rock (University of Massaschusetts Medical Center, Worcester, MA).nature of TCR engagement rather than by nonspecific
cytokine stimuli. The observation that Bcl-xg, but not
T Cell Activation after CD3 LigationBcl-xL, expression by immature (DP) thymocytes re-
Plates precoated with anti-CD3-e (145.2C11, Pharmingen) by over-quires host MHC products suggests that TCR ligation
night incubation (5 mg/ml in phosphate-buffered saline [PBS] [pHis also necessary for Bcl-xg expression in this tissue. It
8.5], 378C) were given O3 T cell clone (1 3 106/ml) and incubated
is possible that expression of other isoforms such as (378C) in DMEM plus 5% fetal bovine serum for the indicated time
Bcl-xL may be important to guarantee survival of imma- frames before staining with Hoechst 33342 dye and PI and analysis
by flow cytometry, as described (Ormerod et al., 1993; Weber et al.,ture DP thymocytes long enough to provide a cellular
1997). After dead cells had been gated out, activated T cell blastssubstrate for positive and negative selection. Expres-
were sorted into Hoechst-negative (nonapoptotic) and Hoechst-sion of Bcl-xg after TCR engagement but not other stim-
positive (apoptotic) subpopulations on a Becton Dickinson flow cy-
uli may represent a genetic mechanism that converts tometer. In experiments with CTLL-2 transfectants, two sets of con-
the interaction between peptide ligand and the TCR into ditions were used: one to achieve high levels and one to achieve
a signal leading to successful activation and positive low levels of of CD3-dependent activation and apoptosis. In the first
case, 5±10 mg/ml anti-CD3 was used to coat the plates, and forselection. According to this view, failure to induce Bcl-
low-level stimulation and apoptosis, reduced concentrations of anti-xg would lead to apoptosis and deletion.
CD3 were used and cells were grown in IL-2 until just prior to theThe factors that induce Bcl-xg expression following assay.
TCR ligation are not addressed here. We have reported
earlier that successful activation or apoptosis is deter- Overexpression of Bcl-xg Sense and Antisense
mined by the relative levels of two distinct signaling cDNAs in CTLL-2 Cells
pathways connected to the TCR (Weber and Cantor, The plasmid pRC/RSV containing enhancer±promoter sequences
from the Rous sarcoma virus (RSV) long terminal repeat (Invitrogen,1994; Weber et al., 1996). One pathway, marked by an
San Diego, CA) was used to construct pRC/RSV-Bcl-xL by insertingincrease in intracellular reactive oxygen intermediates,
a 0.75 kb fragment that contained a full-length ORF of Bcl-xL. Theleads to apoptosis. A second signaling pathway, associ-
pRC/RSV-Bcl-xg vector was constructed by inserting a 1.0 kb frag-
ated with phosphatidylinositol turnover, leads to suc- ment containing the full-length ORF of Bcl-xg. The pRC/RSV-Bcl-
cessful activation and, according to the studies shown xg antisense vector was constructed by cloning a 0.4 kb XbaI±HindIII
Bcl-xg±specific fragment in reverse orientation in a HindIII±XbaI lin-here, may selectively induce Bcl-xg expression. Al-
earized pRC/RSV vector. This 0.4 kb Bcl-xg± specific fragment wasthough additional experiments are required to test this
produced by PCR amplification with an XbaI- containing primerhypothesis directly, the definition of a tissue-restricted
specific for Bcl-xg coding region 59-GGCCTCTAGAGGTGTGAGTG
Bcl-x isoform and its role in T cell apoptosis after TCR GAGGTACACCC-39 and a HindIII- containing primer specific for Bcl-
ligation represents an important step toward a molecular xg noncoding region 59-GGCCAAGCTTCGTCCTTCCTGAAGTCCT
CCT-39. Correct orientation of Bcl-xL, Bcl-xg, and Bcl-xg antisenseexplanation of T cell activation and death.
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inserts in the recombinant vector was confirmed by restriction en- for the Bcl-x common region for amplification of Bcl-xDTM and Bcl-
xb fragments, respectively. A pair of primers of mouse b-actin waszyme digestion and DNA sequencing. Stable expression of the
CTLL-2 T cell line was achieved after transfection with 10 mg of used as an internal control for RT-PCR to ensure the use of similar
amounts of total RNA and cDNA in every experiment. Oligonucleo-XbaI-linearized vector by electroporation in a Gene-Pulser II (Bio-
Rad, Hercules, CA) at 270 V and 950 mF for 20 ms. tides used as primers for PCR amplification of the mouse b-actin
fragment were 59-ATGGATGACGATATCGCTGC-39 and 59-CTATwo days after transfection, T cells werediluted into 96-wellplates
at 5 3 103 cells/0.1 ml or 1 3 104 cells/0.1 ml/well in media containing GAAGCACTTGCGGTGCAC-39. Primers specific for IL-2, IL-3, and
IFNg were used as positive controls for T cell activation in RT-750 mg/ml G418. After 2 weeks, individual clones resistant to G418
were selected, expanded, and maintained in medium containing 250 PCR. Oligonucleotides used as primers for PCR amplification of the
mouse IL-2 fragment were 59-TTCAAGCTCCACTTCAAGCTC-39 andmg/ml G418. In addition, the empty vector pRC/RSV was used to
simultaneously transfect and expand CTLL-2 cells according to the 59-GACAGAAGGCTATCCATCTCC-39. Primer sequences for PCR
amplification of the mouse IFNg fragment were 59-TGCATCTTGGCsame protocol. RT-PCR was performed to confirm efficient expres-
sion of Bcl-x genes in the transfected clones using RNA after diges- TTTGCAGCTCTTCCTCATG-39 and 59-GGACCTGTGGGT-TGTTGA
CCTCAAACTTG-39. PCR-amplified fragments were analyzed ontion with RNase-free DNase before RT to avoid contamination of
RNA preparations. Total RNA from Bcl-xL and Bcl-xg transfectants agarose gels followed by scanning and quantitation using an IS-
1000 digital imaging system (Alpha Innotech), with exposure timesand cells transfected with the pRC/RSV control vector was amplified
by RT-PCR, separated on agarose gels, and confirmed by Southern adjusted so that the intensityof DNA fragment signals corresponded
to the linear range of densitometric detection. To ensure that com-blot hybridization with a 32P-labeled DNA probe prepared from the
cDNA coding for the Bcl-x common region. Bcl-xg antisense parisons of cDNA levels in different samples were based on the
same amount of cDNA in each sample, the area under the densito-transfectants were verified by RT-PCR amplification of total RNA
with an upstream primer specific for vector sequence between pro- metric peak of each sample was divided by the area under the
b-actin densitometric peak for the corresponding sample. The ratiosmoter and insert and a downstream Bcl-xg antisense±specific
primer. of Bcl-x isoform and control (IL-2 or IFNg) cDNA to b-actin cDNA
for each sample were expressed as relative densitometric units.
PCR reactions were typically performed through 35±45 cycles usingIsolation of cDNA Clones and DNA Sequencing
Taq DNA polymerase (Perkin-Elmer) supplemented with TaqStartA mouse thymus l ZapII cDNA library derived from BALB/cJ mice
antibody to maintain the specificity of amplified fragments (Clon-(Stratagene, La Jolla, CA) was screened with a 32P-labeled 60-mer
tech). Each three-step thermal cycle consisted of 30 s at 948C, 30oligonucleotide derived from a human Bcl-x cDNA sequence that
s at 608C, and 30 s at 728C. To encompass the exponential phaseis homologous to a conserved region of chicken Bcl-x (bp 423±483)
of the amplification, 25 ml of the reaction mix was removed at regular(Boise et al. 1993) and hybridized to approximately 106 phages blot-
intervals during PCR, as previously described (Moore et al., 1994).ted on 20 filters according to Wood et al. (1985) and Jacobs et
PCR products in 10 ml for each sample visualized by agarose gelal. (1988). Six positive clones were identified and subcloned into
electrophoresis and ethidium bromide staining were positively iden-Bluescript plasmids, and positive DNA inserts were sequenced
tified by size, andBcl-xg fragments were further confirmed by South-(twice each) by a double-stranded DNA dideoxy chain termination
ern blot hybridization. A negative control containing all reagentsmethod using T7 DNA polymerase (US Biochem).
except cDNA was included in each PCR analysis.
In Vitro Transcription and Translation
Southern Blot Hybridization
Recombinant Bluescript plasmids containing cDNA from Bcl-xL,
The RT-PCR products amplified with Bcl-xg±specific primers were
Bcl-xS, Bcl-xb, and Bcl-xg (1 mg/each) were linearized with a unique
separated on agarose gels, blotted ontoa nylon filters (Micron Sepa-
PstI restriction enzyme at polycloning sites. In vitro transcription
rations), and subjected to ultraviolet-crosslinking. A 360 bp Bcl-
and translation were then performed at 308C for 90 min using a TNT
xg±specific probe prepared by PCR amplification from the recombi-
T7/T3-coupled reticulocyte lysate system for a total reaction volume
nant plasmid Bcl-x7 encoding Bcl-xg using primers that do not
of 50 ml each, according to the manufacturer's protocol (Promega).
overlap with the primers was used to detect gene expression, fol-
Newly synthesized and [35S]methionine- labeled proteins (5 ml/each)
lowed by labeling with [a-32P]dCTP (3000 Ci/mmol, New England
were then analyzed by a 12% sodium dodecyl sulfate polyacryl-
Nuclear) by random oligomer priming (Oligolabeling kit, Pharmacia).
amide gel electrophoresis (SDS-PAGE) and subjected to autoradi-
Radiolabeled probes were purified using Nick-spin columns (Phar-
ography.
macia) to remove excess unincorporated radioactive nucleotides
before hybridization overnight at428C in 63 sodium chloride/sodium
PCR Cloning citrate (SSC) buffer containing 50% formamide. The filters were
Total RNA from murine thymus (BALB/cJ) was reverse transcribed washed in 23 SSC containing 0.1% SDS at 428C for 30 min and in
on a GeneAmp PCR 9600 (Perkin-Elmer) using a GeneAmp RNA- 0.23 SSC containing 0.1% SDS at 658C for 30 min, followed by
PCR kit (Perkin-Elmer Cetus) at 428C for 30 min, 998C for 5 min, and autoradiography.
48C for 5 min, according to the manufacturer's protocols. We used
a primer specific for the 59 upstream Bcl-x common region (59- Apoptosis Assays
TCGCTCGCCCACATCCCAGCTTCACATAACCCC-39) and a second Plates precoated with anti-mouse CD3 antibody (1±10 mg/ml,
primer specific for the 39 downstream Bcl-xg region (59-CTGGTT 145.2C11 Pharmingen) were washed three times before addition of
CGGCCCACGTCCTTCCTGAAGT-CCTCC-39) for PCR cloning. Am- CTLL-2 clones that had been washed three times with IL-2±free
plification products were separated by agarose gel, purified with RPMI 1640 medium supplemented with 5% FCS and incubated at
Geneclean II kit (Bio101), subcloned into the PCR-Direct vector, and 2 ml/well at a concentration of 1.25 3 105 /ml at 378C for 24 hr. In
sequenced by dideoxy chain termination. some experiments intended to maximize CD3-induced apoptosis,
incubation medium was replaced, at 6 and 12 hr after cells were
plated, with fresh RPMI 1640 medium supplemented with 5% FCSGene Expression Measured by RT-PCR
Total RNA extracted from murine tissues was homogenized using to reduce secondary responses to potential growth factors secreted
by cells activated after TCR ligation. The percentage of cells under-RNAzol B (Tel-Test) before RT-PCR was performed. In addition to
the primers used, a primer containing a 39 region unique to Bcl-xL going apoptosis for each transfected clone was analyzed by PI
staining (Broome et al., 1995; McGahon et al., 1995). In brief, 18±24and Bcl-xS (59-CCACCAACAAGACAGGCT-39) was used to pair with
the 59 primer from the Bcl-x common region for amplification of the hr after activation by plate-bound anti-CD3, cells were harvested,
rinsed twice with cold PBS containing 5 mM EDTA, fixed with 50%Bcl-xL fragment. Similarly, a primer complementary to the 39 specific
region of Bcl-xDTM (59-CTCTCCTCCCTCA-CACACCCCTCTC-39) ethanol in PBS containing 5 mM EDTA for 30 min at room tempera-
ture, treated with 40 mg/ml of DNase-free RNase A in PBS for 30and primer 3ep (59-AAGATACAGGTCCCTTAAA-39) complementary
to the 39 specific region of Bcl-xb were used to pair with a 59 primer minutes, and stained with 50 mg/ml of PI in PBS before analysis in
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an Epics XL flow cytometry system using a standard setting in with an anti-rabbit immunoglobulin peroxidase conjugate (Boeh-
ringer Mannheim). After washing, blots were subjected to fluorog-semilogarithmic mode (Coulter). Since partial loss of DNA from
apoptotic cells due to activation of endogenous endonuclease(s) raphy.
and/or marked condensation of the chromatin accompanies
apoptosis and renders these areas of DNA inaccessible to PI stain- Acknowledgments
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